《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2012年 > 5期

餐后2小时C肽与空腹C肽比值(C2/C0)作为预测新诊断的2型糖尿病胰岛素强化治疗指标的观察

来自:中国糖尿病资讯网  编辑:editor|点击数:|2012-05-31

  ·糖尿病的胰岛素治疗·

  作者单位:226001江苏,南通大学附属医院内分泌科

  餐后2小时C肽与空腹C肽比值(C2/C0)作为预测新诊断的2型糖尿病胰岛素强化治疗指标的观察

  唐祝奇 崔世维 朱晓晖 王粹芳 印彤

  【摘要】目的探讨100 g馒头餐2 hC-P与FC-P比值(C2/C0)在胰岛素强化治疗中的临床意义。方法新诊断的T2DM患者87例,分为Ⅰ组(C2/C0≥3,n=43)和Ⅱ组(C2/C0<3,n=44),经2~3周的胰岛素强化治疗,随访3个月,比较两组间的降糖方案和血糖控制情况。结果Ⅰ组比Ⅱ组有更多的患者可采用单独生活方式干预控制血糖良好(20/43 vs 5/44,P<0.05);Ⅱ组比Ⅰ组有更多的患者需胰岛素控制血糖(21/44 vs 9/43,P<0.05);需用口服降糖药者两组间病例数上差异无统计学意义(14/43 vs 18/44, P>0.05),Ⅰ组患者比Ⅱ组患者需要的口服降糖药少。结论新诊断的T2DM患者的C2/C0比值,可作为胰岛素强化治疗的预测指标,C2/C0≥3的患者胰岛素强化治疗的获益更大。

  【关键词】糖尿病,2型;C肽; 血糖;胰岛素强化治疗

  doi:10.3969/j.issn.1006-6187.2012.05.010

  The C2/C0 ratio (2 h postprandial over fasting C-peptide ratio) may be a predictive index for glucose control after insulin intensive therapy in newly diagnosed type 2 diabetesTANG Zhu-qi, CUI Shi-wei,ZHU Xiao-hui, et al. Department of Endocrinology. The Affiliated Hospital of Nantong University. Jiangsu Nantong 226001, China

  【Abstract】ObjectiveTo investigate whether the ratio of the 2 h postprandial to fasting C-peptide(C2/C0) can be a predictive index for glucose control after intensive insulin therapy in newly diagnosed type 2 diabetes. MethodsEighty-seven newly diagnosed type 2 diabetic inpatients were divided into two groups: groupⅠ(C2/C0 ratio≥3,n=43)and group Ⅱ(C2/C0 ratio<3,n=44), then treated with continuous subcutaneous insulin infusion for 2~3 weeks, followed up after 3 months. The levels of glycemia control were compared between two groups. ResultsCompared to group Ⅱ, there were more patients in group Ⅰ getting good glycemia control by life style intervention alone(20/43 vs 5/44, P<0.05). Group Ⅱ showed that more patients (21/44 vs 9/43, P<0.05) needed insulin treatment, as compared to group Ⅰ. ConclusionsThe ratio of C2/C0 can be used as a predictive index for glycemia control after short-term intensive insulin therapy in newly diagnosed type 2 diabetic patients. The patients with C2/C0≥3 can get more benefits from short-term intensive insulin therapy than those with C2/C0<3.

  【Key words】Diabetes mellitus,type 2; C-peptide; Blood glucose; Intensive therapy.

上一篇:地特胰岛素联合瑞格列奈治疗新诊断2型糖尿病患者疗效及安全性的观察 下一篇:2型糖尿病口服药控制不佳起始胰岛素治疗的临床观察